← Back to Search

Behavioural Intervention

Intervention- BT-NCBT-00x for Non-alcoholic Fatty Liver Disease

N/A
Waitlist Available
Research Sponsored by Better Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This single arm interventional cohort study is designed to explore the feasibility of using BT-NCBT-00x to improve liver fat, inflammation, and stiffness in patients diagnosed with NAFLD or NASH over a 3 month intervention.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Liver
Secondary outcome measures
Change in Liver Fat- all participants
Liver

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention- BT-NCBT-00xExperimental Treatment1 Intervention
The treatment, BT-NCBT-00x, consists of a software as a medical device developed by the study Sponsor, Better Therapeutics. It delivers treatment to participants with cardiometabolic disease, using behavioral therapy that targets individual behaviors related to improving dietary quality and physical activity. BT-NCBT-00x is accessed via the participants' smartphone after downloading from the phone's corresponding app store. Participants will receive behavioral support by the Better Therapeutics patient services team in the form of phone calls as necessary or requested by the patient
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BT-NCBT-00X
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Better TherapeuticsLead Sponsor
4 Previous Clinical Trials
1,744 Total Patients Enrolled
Arizona Liver HealthUNKNOWN
1 Previous Clinical Trials
39 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH
2022. "Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05357248.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top